Lim Bryant David Insider Trades

Insider Trading History

Track insider trading activity for Lim Bryant David. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Prelude Therapeutics
Prelude Therapeutics PRLD
Clo, Cfo, Corp Sec.
Holding Value $1.01M 275,000 shares
Last Trade
Feb 04, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$633k 275,000 shares
$2.30
$3.66
Prelude Therapeutics
Prelude Therapeutics PRLD
Clo, Cfo, Corp Sec.
Holding Value $732k 200,000 shares
Last Trade
Feb 04, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$222k 200,000 shares
$1.11
$3.66
Prelude Therapeutics
Prelude Therapeutics PRLD
Clo, Interim Cfo, Corp Sec.
Holding Value $100k 27,400 shares
Last Trade
Dec 19, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$22.8k 25,000 shares
$0.91
$3.66
Prelude Therapeutics
Prelude Therapeutics PRLD
Clo, Interim Cfo, Corp Sec.
Holding Value $91.5k 25,000 shares
Last Trade
May 14, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$96.5k 25,000 shares
$3.86
$3.66
Prelude Therapeutics
Prelude Therapeutics PRLD
Chief Legal Officer, Corp Sec.
Holding Value $549k 150,000 shares
Last Trade
Mar 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$689k 150,000 shares
$4.59
$3.66
Prelude Therapeutics
Prelude Therapeutics PRLD
Chief Legal Officer, Corp Sec.
Holding Value $8.78k 2,400 shares
Last Trade
May 24, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$12.9k 2,400 shares
$5.39
$3.66
Prelude Therapeutics
Prelude Therapeutics PRLD
Chief Legal Officer, Corp Sec.
Holding Value $915k 250,000 shares
Last Trade
Mar 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.48M 250,000 shares
$5.93
$3.66
Idera Pharmaceuticals
Idera Pharmaceuticals IDRA
Holding Value $10.8k 25,400 shares
Last Trade
Jan 20, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.8k 25,400 shares
$0.42
$0.42
Idera Pharmaceuticals
Idera Pharmaceuticals IDRA
Director, SVP AND GENERAL COUNSEL
Holding Value $132k 309,695 shares
Last Trade
Jan 06, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$85.2k 119,957 shares
$0.71
$0.42
Idera Pharmaceuticals
Idera Pharmaceuticals IDRA
Director, SVP AND GENERAL COUNSEL
Holding Value $183k 429,652 shares
Last Trade
Jan 06, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$283k 399,218 shares
$0.71
$0.42
Idera Pharmaceuticals
Idera Pharmaceuticals IDRA
Director, SVP AND GENERAL COUNSEL
Holding Value $28.3k 66,500 shares
Last Trade
Jul 06, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$28.8k 66,500 shares
$0.43
$0.42
Idera Pharmaceuticals
Idera Pharmaceuticals IDRA
Director, SVP AND GENERAL COUNSEL
Holding Value $17.6k 41,500 shares
Last Trade
Apr 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22.2k 41,500 shares
$0.53
$0.42
Idera Pharmaceuticals
Idera Pharmaceuticals IDRA
Holding Value $10.6k 25,000 shares
Last Trade
Jan 24, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$14.3k 25,000 shares
$0.57
$0.42
Idera Pharmaceuticals
Idera Pharmaceuticals IDRA
Holding Value $28.3k 66,500 shares
Last Trade
Jul 08, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$73.8k 66,500 shares
$1.11
$0.42
Idera Pharmaceuticals
Idera Pharmaceuticals IDRA
Holding Value $12.9k 30,434 shares
Last Trade
Mar 25, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$10.4k 7,630 shares
$1.36
$0.42
Idera Pharmaceuticals
Idera Pharmaceuticals IDRA
SVP And General Counsel
Holding Value $16.2k 38,064 shares
Last Trade
Jan 12, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$7.2k 1,711 shares
$4.21
$0.42
Idera Pharmaceuticals
Idera Pharmaceuticals IDRA
SVP And General Counsel
Holding Value $21.7k 51,000 shares
Last Trade
Jan 08, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$218k 51,000 shares
$4.28
$0.42
Idera Pharmaceuticals
Idera Pharmaceuticals IDRA
SVP And General Counsel
Holding Value $16.9k 39,775 shares
Last Trade
Jan 05, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.73k 1,465 shares
$3.91
$0.42
Idera Pharmaceuticals
Idera Pharmaceuticals IDRA
SVP And General Counsel
Holding Value $21.3k 50,000 shares
Last Trade
Jul 21, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$124k 50,000 shares
$2.48
$0.42
Idera Pharmaceuticals
Idera Pharmaceuticals IDRA
SVP And General Counsel
Holding Value $21.3k 50,000 shares
Last Trade
Jan 10, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$125k 70,000 shares
$1.79
$0.42

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up